期刊文献+

多肽P110结合顺铂对多种肿瘤细胞杀伤作用的研究 被引量:7

The cytotoxic effect of polypeptide P110 plus cisplatin on various cancer cells
下载PDF
导出
摘要 目的探讨多肽P110联合顺铂对不同肿瘤细胞的杀伤效应及其对顺铂的可能增敏作用。方法采用胃癌细胞SGC-7901、结肠癌细胞HCT-116、宫颈癌细胞HeLa、肺癌细胞A-549、人脐静脉血管内皮细胞(HUVEC)细胞系。MTT法检测顺铂(DDP)组、P110组及顺铂+P110组对上述细胞生长的影响,及P110对顺铂在不同肿瘤细胞中的增敏作用。结果 P110或顺铂对不同肿瘤细胞的增殖均有明显抑制作用,且呈浓度依赖性;多肽P110联合不同浓度顺铂对不同肿瘤细胞的抑制率均高于顺铂组,差异有统计学意义(P<0.05),其中,P110联合10μmol.L-1顺铂杀伤HCT-116和HeLa细胞的效果与高浓度顺铂(30、90μmol.L-1)相当,且对HUVEC细胞的毒性作用较小;在相同浓度梯度下,P110联合顺铂对宫颈癌HeLa细胞的杀伤作用均优于其他肿瘤细胞(P<0.01)。结论多肽P110可以增强顺铂抗肿瘤作用,联合用药可以减少顺铂的用量,减轻对HUVEC的毒性作用;多肽P110单独使用亦有一定的杀伤作用;联合用药时对宫颈癌HeLa细胞的杀伤效果最好。 Aim To study the cytotoxic effect of polypeptide P110 combined with cisplatin on cancer cells and the probable sensitizing effect on cisplatin.Methods Cell lines of SGC-119,HCT-119,HeLa,A-549,HUVEC were used.MTT was used to measure inhibitory effects on the growth of SGC-119,HCT-119,Hela,A-549,HUVEC cells.Results Cisplatin(or P110) dose-dependently inhibited proliferation of SGC-7901,HCT-116,HeLa and A-549.The inhibitory rate of P110 combined with cisplatin(3.3,10,30,90 μmol·L-1)was more than that of cisplatin single group(P0.05);10 μmol·L-1 cisplatin combined with P110 could achieve the greatest anti-tumor effect on HCT-116 and HeLa cells,and least toxicity on HUVEC cells.At the same concentration gradient,the cytotoxic effect on Hela was better than others(P0.01).Conclusions Polypeptide P110 can enhance the cytotoxic effect of cisplatin on gastric cancer cell line SGC-119,colon cancer cell line HCT-119,cervical carcinoma cell line HeLa and lung cancer cell line A-549.Polypeptide P110 alone has the cytotoxic effect on cancer cells too.Cisplatin combined with P110 can reduce the dose of cisplatin,and cut down the toxicity on HUVEC cells.The cytotoxic effect on cervical carcinoma cell line HeLa is the best.
出处 《中国药理学通报》 CAS CSCD 北大核心 2011年第12期1728-1731,共4页 Chinese Pharmacological Bulletin
基金 湖北省科技厅自然科学基金资助项目(No2010CDB06908)
关键词 恶性肿瘤 顺铂 多肽 增敏 计算机辅助药物设计 联合用药 cancer cisplatin polypeptide sensitization computer-aided drug design combination therapy
  • 相关文献

参考文献4

二级参考文献29

  • 1刘杰,计亮年,梅文杰.金属钌配合物的抗肿瘤活性及其作用机理[J].化学进展,2004,16(6):969-974. 被引量:24
  • 2董民声 董明敏 娄卫华 见:董民声 董明敏 娄卫华主编.顺铂耳毒作用及其防治[A].见:董民声, 董明敏, 娄卫华主编.内耳疾病研究进展[C].郑州:河南医科大学出版社,1999.75~8.
  • 3Wong E,Giandomenico C M.Current status of platinum-based antitumor drags[J].Chem Rev,1999,99(9):2451-66.
  • 4Perez J M,Fuertes M A,Alonso C,et al.Current status of the development of trans plantinum antitumor drugs[J].Crit Rev Oncol Hematol,2000,35:109-20.
  • 5McKeage MJ.Lobaplatin:a new antitumor platinum drug[J].Expert Opin Investig Drugs,2001,10(1):119-28.
  • 6Perego P,Caserini C,Gatti L,et al.A novel trinuclear platinum complexes overcomes cisplatin resistance in an osteosarcoma cell system[J].Mol Pharmcol,1999,55(3):528-34.
  • 7Perez J M,Camazon M,Alvarez-Valdes A,et al.Synthesis,characterization and DNA modification induced by a novel Pt(Ⅳ)-bis (monoglutarate)complex which induces apoptosis in glioma cells[J].Chem Biol Interact,1999,117(2):99-115.
  • 8Mishra L,Sinha R,Itokawa H,et al.Anti-HIV and cytotoxic activities of Ru(Ⅱ)/Ru(Ⅲ) polypyridyl complexes containing 2,6-(2'-benzimidazolyl)-pyridine/chalcone as co-ligand[J].Bioorg Med Chem,2001,9:1667-71.
  • 9Alessio E,Iengo E,Zorzet S,et al.Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(Ⅲ) compounds Na2[[trans-RuCl4(Me2SO)]2(mu-L)](L=ditopic,non-chelating aromatic N-ligand).A preliminary investigation[J].J Inorg Biocham,2000,79(1-4):173-7.
  • 10Sara G,Bergamo A,Zorzet S,et al.Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A[J].Eur J Cancer,2002,38(3):427-35.

共引文献58

同被引文献83

  • 1魏丽惠.宫颈癌相关治疗[J].中国医学前沿杂志(电子版),2010,2(2):38-41. 被引量:2
  • 2汪少芸,叶秀云,饶平凡.植物非特异脂转移蛋白的研究[J].生物学通报,2004,39(9):11-12. 被引量:9
  • 3蔡先彬,荆绪斌,胡辉,陈素钻,李映华.活性氧在顺铂诱导食管癌细胞EC-109凋亡中的作用[J].癌症,2006,25(4):427-431. 被引量:10
  • 4黄红莹,刘广超,齐义军,杜耀武,马远方.双歧杆菌联合顺铂对黑色素瘤小鼠的治疗作用及机制[J].第四军医大学学报,2007,28(21):1947-1950. 被引量:1
  • 5Sawano Y, Hatano K, Miyakawa T, et al. Proteinase inhibitor from gink- go seeds is a member of plant nonspecific lipid transfer protein gene family[ J]. Plant Physiol,2008,146 : 1409 - 1919.
  • 6Kim T H, Kim M C, Park J H, et al. Differential expression of rice lipid transfer protein gene (LTP) classes in response to abscisic acid, salt, sali- cylic acid, and the fungal pathogen Magnaporthe grisea [J~. Journal of Plant Biology, 2006,49 ( 5 ) : 371 - 375.
  • 7Ma X J,Liu D L,Tang H S ,et al. Purification and characterization of a novel protein from Peganum harmala seeds with antifungal, antiproliferation and anti -HIV - 1 reverse transcriptase activities [ J]. Acta Biochim Bio- phys Sin,2013,45(2) :87 -94.
  • 8Cao S S ,Zhen Y S. Potentiation of antimetabolite antitumor activity invivo by dipyridamole and amphotericin B [ J]. Cancer Chemother Pharma- col,1989,24(3) : 181 -186.
  • 9Blankenberg F G. Recent advances in the imaging of programmed cell death [ J ]. Curr Pharm,2004,10 : 1457 - 1467.
  • 10Xue C, Huang Y, Huang PY, et al. Phaes 1] study of sorafenib in combination whir cisplatin and 5 - fluoruracil to treat recurrent or metastatic nasophayngeal carcinoma [J]. Ann 0ncol,2013,24 (4) : 1055 -1061.

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部